Research Publications

Our Numbers

500+

Publications

49,600+

Total Times Cited

12,119

Most Times Cited

12+ Mil.

number of single cells analyzed

620 TB

of data generated

10.000+

Yearly Patient Screens

Publication List

Hong X, Xiao Y, Qi H, Zhu S, Filla T, Györfi AH, Li YN, Xu M, Zhi L, Trinh-Minh T, Dees C, Schett G, Distler JHW, Matei AE. Linezolid prevents fibroblast activation and ameliorates tissue fibrosis by inhibition of mitochondrial translation. Arthritis Rheumatol. 2025 Nov 14. doi: 10.1002/art.43440. Online ahead of print.PMID: 41236049

Li YN, Filla T, Györfi AH, Liang M, Devakumar V, Micu A, Chai H, Bergmann C, Pecher AC, Henes J, Moinzadeh P, Al-Gburi S, Krieg T, Kreuter A, Wang J, Schett G, Homey B, Dietrich S, Distler JHW, Matei AE. Spatially informed phenotyping by cyclic-in-situ-hybridisation identifies novel fibroblast populations and their pathogenic niches in systemic sclerosis. Ann Rheum Dis. 2025 Nov;84(11):1852-1864. doi: 10.1016/j.ard.2025.06.002. Epub 2025 Jul 1.PMID: 40603206

Ueberall L, Mohammadian H, Demmler R, Ariza Y, Tripal P, Anchang CG, Weber S, Angeli MR, Raimondo MG, Chang J, Huang K, Distler JHW, Distler O, Rauber S, Schett G, Ramming A, Ramming AM. Matrix stiffness regulates profibrotic fibroblast differentiation and fibrotic niche activation in systemic sclerosis. Ann Rheum Dis. 2025 Nov;84(11):1865-1876. doi: 10.1016/j.ard.2025.05.016. Epub 2025 Jun 26.PMID: 40579317

Distler JHW, Kuwana M, Assassi S, Denton CP. Emerging therapies for the treatment of systemic sclerosis. Nat Rev Rheumatol. 2025 Oct;21(10):612-625. doi: 10.1038/s41584-025-01294-x. Epub 2025 Sep 8.PMID: 40921742

Page 1 of 1